| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $3,278,603 ) |
| | 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01NS116037 | Overcoming Resistance Mechanisms in Hedgehog and Myc-amplified Medulloblastoma | 000 | 5 | NIH | 11/29/2024 | $360,639 |
| | 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AI145542 | Prodrug Formulations Create Sustained-Release Antiretrovirals | 001 | 6 | NIH | 11/18/2024 | $744,473 |
| | 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R35GM152032 | DNA Replication Machines: Structure-Function Studies | 001 | 2 | NIH | 11/5/2024 | $455,895 |
| | 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AI168315 | Proteostasis in Plasmodium falciparum artemisinin resistance | 000 | 2 | NIH | 11/18/2024 | $747,604 |
| | 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL171602 | Nrf2 and the exaggerated Exercise Pressor Reflex in Peripheral Arterial Disease | 000 | 2 | NIH | 11/22/2024 | $564,745 |
| | 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL137832 | Mechanisms of cardiac sympathetic hyperactivity in chronic heart failure | 000 | 7 | NIH | 11/26/2024 | $580,561 |
| | 2025 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R35GM144102 | Mechanisms of membrane trafficking in endocytic and non-endocytic pathways | 000 | 3 | NIH | 11/11/2024 | $0 |
| | 2025 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R21CA280020 | Targeting FGFR4 to overcome chemoresistance in ovarian cancer | 000 | 1 | NIH | 11/5/2024 | -$153,539 |
| | 2025 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R35GM151971 | Investigating the function of bacterial cytoskeletal elements in the division and growth of the FtsZ-less Chlamydia | 000 | 1 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R35GM152032 | DNA Replication Machines: Structure-Function Studies | 000 | 1 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | P20GM152326 | Nebraska Center for Heart and Vascular Research | 000 | 1 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01MD019506 | Mobile Health for Migrant Health (mHealth-4-Mhealth): Assessing the Effectiveness of Implementing an mHealth Program to Increase COVID-19 Testing and Treatment Among Rural Migrant Families | 000 | 1 | NIH | 10/10/2024 | $0 |
| | 2025 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | CPIMP231377 | The COMSS ADVancing Ongoing Community AcTivities for Equitable Systems (COMSS ADVOCATES) | 01 | 2 | DHHS/OS | 11/14/2024 | $0 |
| | 2025 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U54OH010162 | Surveillance of Agricultural Injuries in the Central States Regions | 02 | 13 | CDC | 10/4/2024 | $0 |
| | 2025 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U54OH010162 | Surveillance of Agricultural Injuries in the Central States Regions | 02 | 13 | CDC | 10/4/2024 | $0 |
| | 2025 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DA061678 | Sex differences in modulating HIV/SIV reservoirs in the context of opioids | 000 | 1 | NIH | 11/27/2024 | $0 |
| | 2025 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R03TR004473 | PIP5K1A is a novel mutant KRAS effector and essential for pancreatic cancer cell survival | 000 | 1 | NIH | 11/13/2024 | $0 |
| | 2025 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R00CA230312 | ARF6 function in cancers driven by RAS hyperactivation | 000 | 5 | NIH | 11/8/2024 | $0 |
| | 2025 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AI145542 | Prodrug Formulations Create Sustained-Release Antiretrovirals | 000 | 5 | NIH | 11/17/2024 | $0 |
| | 2025 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R21OD034048 | Enhancement of Human Immune System Development in Mouse Models | 000 | 2 | NIH | 11/13/2024 | $0 |
| | 2025 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | CPIMP231377 | The COMSS ADVancing Ongoing Community AcTivities for Equitable Systems (COMSS ADVOCATES) | 01 | 2 | DHHS/OS | 11/14/2024 | $0 |
| | 2025 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U3N45394 | Health and Public Safety Workforce Resiliency Training Program | 03 | 2 | HRSA | 11/7/2024 | $0 |
| | 2025 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | E4C18103 | NSL - Baccalaureate Nursing | 001 | 2 | HRSA | 10/1/2024 | $0 |
| | 2025 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | E1114843 | HPSL - Dentistry | 001 | 3 | HRSA | 10/18/2024 | $0 |
| | 2025 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U54OH010162 | Surveillance of Agricultural Injuries in the Central States Regions | 02 | 13 | CDC | 10/4/2024 | $0 |
| | 2025 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R21HD105880 | RBC TRANSFUSION IN ANEMIC NEONATES LEADS TO SYSTEMIC INFLAMMATORY RESPONSE SYNDROME | 002 | 3 | NIH | 10/30/2024 | $54,693 |
| | 2025 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R21CA256638 | Novel Mechanisms Controlling SCLC Tumor Initiation | 000 | 2 | NIH | 11/5/2024 | -$12,456 |
| | 2025 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AG059785 | Mechanisms of Presynaptic Energetic Failure Due to Age-Related Pathologic Tau Accumulation | 000 | 5 | NIH | 11/5/2024 | $0 |
| | 2025 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R21AR078439 | A Hydrogel Ionic Circuit-Based Electrical Stimulation System for Restoration of Denervated Muscles After Peripheral Nerve Injuries | 000 | 2 | NIH | 11/4/2024 | -$9,979 |
| | 2025 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA218545 | Novel approach to attenuate small cell lung cancer growth and metastasis | 000 | 5 | NIH | 11/5/2024 | $0 |
| | 2025 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | T1433206 | ANE - Nurse Practitioner Residency Program | 03 | 4 | HRSA | 11/13/2024 | -$7,402 |
| | 2025 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AI139176 | Coxiella manipulation of cholesterol in the intracellular niche | 000 | 6 | NIH | 11/22/2024 | $0 |
| | 2025 | 2021 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DA044586 | Combinatorial effects of HIV, cART, & morphine on neuroinflammation: implications for HAND | 000 | 5 | NIH | 11/6/2024 | -$2,536 |
| | 2025 | 2021 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DK114663 | Novel Target Mechanism (Renal Denervation) to Reduce Sodium Retention in Chronic Heart Failure | 000 | 5 | NIH | 10/16/2024 | -$40,565 |
| | 2025 | 2021 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R21NS123495 | REM sleep control by the sublaterodorsal tegmental nucleus glutamatergic neurons | 000 | 2 | NIH | 10/10/2024 | -$3,529 |
| | 2025 | 2019 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R03CA228909 | Effects of the FDA Compliance Inspections of Tobacco Retailers on Youth E-cigarette and Cigar Use: A National Study | 000 | 2 | NIH | 10/1/2024 | -$1 |
|
| Issue Date FY: 2024 ( Subtotal = $98,910,512 ) (Continued on the next page) |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AI169788 | T cell-innate immune crosstalk regulates Staphylococcus aureus craniotomy infection | 000 | 3 | NIH | 2/26/2024 | $522,732 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DE031272 | Biomimetic and Injectable Highly Porous Nanofiber Microsphere-based Platform for Alveolar Bone Regeneration | 000 | 3 | NIH | 3/27/2024 | $486,868 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01NS116037 | Overcoming Resistance Mechanisms in Hedgehog and Myc-amplified Medulloblastoma | 001 | 4 | NIH | 5/6/2024 | $28,051 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | M0152162 | Behavioral Health Workforce Education and Training Program | 00 | 2 | HRSA | 7/10/2024 | $530,000 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL169476 | Optogenetic silencing to achieve antiarrhythmic effect of renal denervation in chronic heart failure | 000 | 2 | NIH | 6/18/2024 | $569,442 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | K08HL171936 | Mechanisms of Complement Activation in Traumatic Injury | 000 | 1 | NIH | 9/15/2024 | $120,096 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R56HD111119 | Reversing disrupted developmental sterol biosynthesis by prescription medications | 000 | 1 | NIH | 8/29/2024 | $230,250 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL164306 | Diastolic Heart Failure in HIV-1 infection | 000 | 3 | NIH | 7/3/2024 | $612,681 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL160820 | Skeletal Muscle Nrf2: Exercise-Induced Cardiovascular Protection | 000 | 3 | NIH | 12/5/2023 | $466,635 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | K23MH125734 | Investigations of antiretroviral therapy penetration in cerebrospinal fluid | 000 | 4 | NIH | 2/6/2024 | $172,463 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | Omaha | NE | 68198-7835 | DOUGLAS | USA | U0117261 | Partnership for Urban MCH Leadership Community | 01 | 14 | HRSA | 4/16/2024 | $393,960 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U0117261 | Partnership for Urban MCH Leadership Community | 02 | 14 | HRSA | 9/16/2024 | $0 |
|
